BENJAMIN GEORGE KESELOWSKY,JAMAL LEWIS,ABHINAV ACHARYA,MICHAEL J. CLARE-SALZLER
申请号：
US16024890
公开号：
US20180303760A1
申请日:
2018.07.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides antigen-specific, tolerance-inducing microparticles for the targeted delivery of therapeutic agents to immune cells. In addition, the present invention allows for sustained release of therapeutic agents for a prolonged period of time. Also provided are therapeutic uses of the present invention for the prevention and/or treatment of immune diseases and autoimmune disorders. In a specific embodiment, the present invention provides treatment for type 1 diabetes.
